Linah Al-Alem holds a PhD in Pharmacology and a masters in Clinical Health Sciences. Dr. Al-Alem is currently a research fellow at the Massachusetts General Hospital and Harvard Medical School focusing on targeted cancer therapies and developing novel cancer diagnostic assays. She is a scientific leader in academic, clinical and small biotech collaborative research projects. She is also a business development fellow at the Harvard office of technology transfer where she assesses innovative technologies emerging from Harvard labs. In her free time, Linah enjoys traveling, playing the piano, singing, dabke dancing, and art.